Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Journal of Medical Virology|March 1, 1985
Clinical evaluation of a monoclonal assay for hepatitis B surface antigen: identification of "HBsAg-like" polypeptides non-reactive in conventional radioimmunoassaysP Karayiannis, A H Goodall, J A Waters, et al.
Social Science & Medicine (1982)|May 24, 2024
Exploring the mechanisms underlying increased risk of depressive disorder in ethnic minority populations in Europe: A causal loop diagramJ M van der Wal, K B S Huth, A Lok, et al.
European Journal of Heart Failure|March 20, 2003
The relevance of heart failure severity for treatment with evidence-based pharmacotherapy in general practiceLisa G Pont, Wiek H van Gilst, Dirk J A Lok, et al.
Gynecologic Oncology|June 23, 2006
Treatment and prognosis of post term choriocarcinoma in The NetherlandsChristianne A Lok, Anca C Ansink, Danielle Grootfaam, et al.
Hepatology (Baltimore, Md.)|March 7, 2001
Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase regionL J Stuyver, S A Locarnini, A Lok, et al.
Blood Reviews|March 13, 2017
p53 dysregulation in B-cell malignancies: More than a single gene in the pathway to hellB Tessoulin, M Eveillard, A Lok, et al.
Journal of Psychiatric Research|January 10, 2022
'Rapid speed of response to ECT in bipolar depression: A chart reviewK W F Scheepstra, J B van Doorn, D S Scheepens, et al.
Journal of Diabetes|June 3, 2011
Strategies to detect abnormal glucose metabolism in people at high risk of cardiovascular disease from the ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial populationErik A Badings, Lyanne Dyal, Lydia Schoterman, et al.
Annals of Medicine|December 30, 2010
Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fractionRudolf A de Boer, Dirk J A Lok, Tiny Jaarsma, et al.
Current Medical Research and Opinion|November 26, 2005
LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) studyJ Wouter Jukema, An-Ho Liem, Peter H J M Dunselman, et al.
Pageof 7